For August 2025, chronic therapies expanded 12 per cent, while acute segments saw a 6 per cent rise. Cardiac drugs recorded an 11 per cent growth, the same rate seen in anti-diabetic medicines, boosted by strong demand for GLP-1 molecules.
Indian Pharmaceutical Market Clocks 8% Growth In August: Report
